Bill Ackman has never been shy about a big swing. But his proposed takeover of Universal Music Group is running into a problem he can’t trade his way around: the largest shareholder doesn’t want to sell, doesn’t like the price, and doesn’t think Ackman is the right person to run the company.

What Happened

Pershing Square submitted a non-binding proposal to UMG’s board in April, valuing the company at approximately €55.8 billion ($64.4 billion), or €30.40 per share – a 78% premium to UMG’s closing price on April 2. Under the terms, shareholders would receive €9.4 billion in cash plus 0.77 shares of new stock per UMG share held. The plan also involved merging UMG into a new NYSE-listed entity, a move Ackman argued would unlock demand from institutional investors currently unable to purchase non-US-listed securities.

Then Bolloré spoke.

At the Bolloré Group’s annual shareholders meeting on May 27, CEO Cyrille Bolloré didn’t mince words. He questioned the bid’s valuation, its funding structure, and Ackman’s management style in a single breath. His three-word verdict: “The price is not there at all.” His broader objection was structural – he argued Ackman was effectively proposing to buy UMG with UMG’s own cash. “He is not making an offer with his own money,” Bolloré told shareholders. “It is our money, the company’s money.”

Bolloré also questioned whether Ackman’s management style – which he described as “more abrupt, more rapid” – was compatible with UMG’s company culture. He said the Bolloré family was under no pressure to sell, noting the group held €5.6 billion in cash and was distributing €4.5 billion to shareholders.

Why This Is Effectively a Veto

This isn’t just pushback. It’s arithmetic. Bolloré Group controls an 18.4% direct stake in UMG. The Bolloré family also holds a 29.3% stake in Vivendi, which itself owns 13.4% of UMG – giving the Bolloré camp effective control of just under 32% of the company’s shares. For Ackman’s bid to move forward, a two-thirds majority of shareholders is required. Ackman himself acknowledged it plainly: “Without Bolloré, we don’t have a transaction.”

UMG stock fell 2.6% on Wednesday following the remarks, trading at €19.78 – well below the €30.40 offer price. On Thursday morning in Amsterdam it was down another 1.9%. The stock has now lost roughly 30% over the past 12 months and still sits below its IPO price from nearly five years ago. One analyst at Square Global told Bloomberg the proposal “looks very much dead from the start.”

Worth noting: UMG did respond to Ackman’s pressure in one way. In April, the company said it would sell half its roughly 3% stake in Spotify – worth about $1.4 billion – after Ackman argued the market was not fully valuing that holding. UMG also increased its share buyback program. So some of his agenda is getting implemented, just without the hostile takeover attached to it.

The Other Pershing Story This Week

Separate from the UMG drama – and this part is actually more relevant to most retail investors – Bank of America initiated coverage on Pershing Square Inc. (NYSE: PS) this week with a Neutral rating and a $42 price target. Analyst Craig Siegenthaler framed Pershing Square as a “Baby Buffett” model: a firm building permanent capital, concentrating into a handful of high-conviction positions, and compounding over decades rather than chasing quarterly flows.

The structural angle is what makes this interesting. Pershing Square became the first hedge fund to market directly to U.S. individual investors following a 2025 SEC policy shift. Combined with its April 2026 IPO of Pershing Square USA (PSUS) on the NYSE, retail investors can now access what used to be an institutional-only structure – a concentrated, actively managed, permanent-capital fund – through a regular brokerage account.

BofA flagged that 96% of Pershing Square’s fee-paying assets under management are permanent capital that cannot be redeemed. That insulates the firm from forced selling and removes the fundraising treadmill that hampers most hedge funds. The firm posted an operating margin of roughly 88% in 2025 on a lean investment team – and has generated annualized returns of 16% since inception, versus 11% for the S&P 500.

But BofA stopped at Neutral for a reason. The bank cited valuation concerns – the stock trades at a significant premium to the roughly 18x average multiple for alternative asset manager peers – concentrated portfolio risk across just 12 to 15 positions, and heavy key-man dependence on Ackman himself. That last point is worth sitting with, especially in a week where his biggest public deal just got shut down in real time.

The Cheap Investor Scorecard

• UMG bid valuation: €30.40/share vs. current ~€19.78 – 54% gap to close
• Bolloré + Vivendi combined blocking stake: ~32% (two-thirds majority required for approval)
• Pershing Square (PS) BofA price target: $42 | Current: ~$35.67 | Implied upside: ~18%
• PS permanent capital ratio: 96% of fee-paying AUM – best-in-class structural insulation
• PS operating margin (2025): ~88% – very high for any asset manager
• PS annualized return since inception: 16% vs. S&P 500’s 11%
• PS portfolio concentration: 12–15 positions – high conviction, high variance
• UMG Q1 2026 revenue: €2.9 billion, up 8.1% year-over-year at constant currency
• UMG Spotify stake sale: half of ~3% stake (~$1.4B) now being liquidated
• UMG stock vs. IPO price: still below debut nearly five years later

Bottom Line

If Bolloré doesn’t move, the UMG deal doesn’t happen. That’s not a prediction – that’s what the math says, and what Ackman himself has admitted. The more interesting question is whether Ackman uses the pressure he’s already applied to extract concessions from UMG management without ever completing a deal. He’s already gotten a Spotify stake sale and a buyback expansion. There may be more to come.

As for Pershing Square the stock – the BofA framing is fair. The structure is genuinely novel for retail access to institutional-grade compounding. The risk is that 96% of the investment thesis is one person. That’s either the best reason to own it or the first reason to think twice.

Worth watching either way.